Seeking Alpha

Seattle Genetics (SGEN -4.8%) and Takeda Pharmaceutical (TKPYY.PK -1.00%) dip after the FDA says...

Seattle Genetics (SGEN -4.8%) and Takeda Pharmaceutical (TKPYY.PK -1.00%) dip after the FDA says it's seen three cases of serious brain infection among patients being treated with their jointly-produced lymphoma drug Adcetris, and strengthened the drug's warning label.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector